[The treatment of disseminated intravascular coagulation in 18 cases of promyelocytic acute leukaemia (author's transl)].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001772:Blood Cell Count; D001779:Blood Coagulation Factors / Q000032:analysis; D001792:Blood Platelets; D001803:Blood Transfusion; D002543:Cerebral Hemorrhage / Q000209:etiology; D003561:Cytarabine / Q000627:therapeutic use*; D003630:Daunorubicin / Q000627:therapeutic use*; D004211:Disseminated Intravascular Coagulation / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D005340:Fibrinogen / Q000032:analysis; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000150:complications*; D008875:Middle Aged; D011379:Prognosis; D012075:Remission, Spontaneous
D001779:Blood Coagulation Factors; D003561:Cytarabine; D005340:Fibrinogen; D006493:Heparin; D003630:Daunorubicin
Traitement dans 18 observations de leucémies aiguës promyélocytaires de la coagulation intravasculaire disséminée